Showing results (551-560 of 942) with videos related to

Sort By:
Pageof 95
The Lancet. Planetary Health|January 10, 2024
Associations between landscape fires and child morbidity in southern Mozambique: a time-series studyAriadna Curto, Jovito Nunes, Carles Milà, et al.
Leukemia Research|August 24, 1999
Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabineP Raanani, O Shpilberg, S Gillis, et al.
Global Health Action|July 28, 2020
The evolution of minimally invasive tissue sampling in postmortem examination: a narrative reviewChristina R Paganelli, Norman J Goco, Elizabeth M McClure, et al.
Ultrasound in Medicine & Biology|June 29, 2025
Novel Artificial Intelligence-Driven Infant Meningitis Screening From High-Resolution Ultrasound ImagingHassan Ahmed Sial, Francesc Carandell, Sara Ajanovic, et al.
The Israel Medical Association Journal : IMAJ|January 28, 2019
Ultrapure Filter does not Confer Short-Term Benefits over Two Reverse Osmosis Systems in Chronic Hemodialysis PatientsAyelet Grupper, Moshe Shashar, Talia Weinstein, et al.
World Journal of Gastroenterology|August 23, 2019
Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide surveySaleh Daher, Tawfik Khoury, Ariel Benson, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Plos One|September 14, 2011
Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican childrenNúria Díez-Padrisa, Ruth Aguilar, Sonia Machevo, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2018
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug AdministrationPere Millat-Martínez, Rhoda Ila, Moses Laman, et al.
European Journal of Haematology|September 7, 2004
Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methodsPia Raanani, Isaac Ben-Bassat, Shlomit Gan, et al.
Pageof 95